Potential impact of biologics and emerging therapies for psoriasis and atopic dermatitis on future fertility: Reassurance to patients but more data are needed

J Am Acad Dermatol. 2017 Oct;77(4):758-763. doi: 10.1016/j.jaad.2017.05.025.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adalimumab / adverse effects
  • Adalimumab / therapeutic use
  • Adult
  • Biological Products / administration & dosage
  • Biological Products / adverse effects*
  • Biological Products / pharmacology
  • Cohort Studies
  • Dermatitis, Atopic / diagnosis
  • Dermatitis, Atopic / drug therapy*
  • Etanercept / adverse effects*
  • Etanercept / therapeutic use
  • Female
  • Humans
  • Infertility, Female / chemically induced*
  • Infertility, Female / epidemiology
  • Infertility, Female / physiopathology
  • Infertility, Male / chemically induced*
  • Infertility, Male / epidemiology
  • Infertility, Male / physiopathology
  • Male
  • Needs Assessment
  • Patient Safety
  • Psoriasis / diagnosis
  • Psoriasis / drug therapy*
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index

Substances

  • Biological Products
  • Adalimumab
  • Etanercept